Facebook Twitter Google+ Post Views: 1,489 EuropeWHO Share the News Facebook Twitter VKontakte Google+ ViiV Healthcare launches phase III programme to evaluate a long-acting, injectable HIV treatment regimen WHO: The use of delamanid in the treatment of MDR-TB in children and adolescents: Interim policy guidance Related News 2071 Behavioral intervention reduces HIV transmission risk in young transgender women 2565 Global progress towards hepatitis C elimination still blocked by cost of treatment, lack of diagnosis 2541 Vladimir Zhovtyak: European AIDS conference is a step forward to control the HIV/AIDS in Europe 2386 Patient Communities Agree on Shared Vision of HIV Treatment Regimen 2927 Glecaprevir/pibrentasvir is effective for people with HIV/HCV co-infection
2565 Global progress towards hepatitis C elimination still blocked by cost of treatment, lack of diagnosis
ПОИСК ПО САЙТУ 
поиск по ресурсному центру 
